Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

US HMO forces antihistamine price cuts

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    US HMO forces antihistamine price cuts. Pharmacoecon. Outcomes News 274, 11 (2000). https://doi.org/10.1007/BF03267312

    Download citation

    Keywords

    • Outcome News
    • Health Plan
    • Cetirizine
    • Medical Officer
    • Health Maintenance Organisation